Clinical Trial

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Name: A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer — clinical trial record (NCT06067841)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.

Protocol Amendment History 1 change

notable Trial sites expanded: 8 -> 15 locations 2026-08-11

Trial Details

NCT Number	NCT06067841
Lead Sponsor	Bristol-Myers Squibb
Conditions	Metastatic Castration-resistant Prostate Cancer
Enrollment	140 participants
Start Date	2023-10-18
Primary Completion	2029-08-24 (estimated)
Study Completion	2031-07-27 (estimated)
Updated on ClinicalTrials.gov	2026-08-10